UNCLAIMED
Emmes
Overview
Emmes is a business services company based in the United States, specializing in research and development within the biotech and pharmaceutical sectors. Founded in 1977, Emmes has developed a substantial workforce, employing between 1,001 and 5,000 individuals. The company has a notable focus on clinical trial management and has been involved in various studies, including a recent case study on cell therapy for multiple myeloma. This study, part of a Phase II multicenter trial, explored the efficacy of a dendritic cell/myeloma fusion vaccine combined with maintenance therapy following autologous transplant. Emmes played a critical role in managing the study, including overseeing the manufacturing processes and ensuring compliance with standard operating procedures. Their collaborative efforts with institutions and regulatory bodies, such as the FDA, highlight their commitment to advancing innovative therapies in the biotech field. Through their involvement in significant clinical trials, Emmes aims to contribute to the development of effective treatments in the healthcare landscape.